National Academy of State Health Policy Provider Survey
HHSC is participating in the National Academy of State Health Policy (NASHP) Maternal Child Health Policy Innovation program and is seeking provider input to gain a better understanding of the current landscape for substance use identification, substance use disorder (SUD) treatment, and referral practices for pregnant and postpartum women enrolled in Medicaid, CHIP (including CHIP-P) or the Healthy Texas Women Program. Your response to the below survey will assist HHSC in developing better training and communication around SUD identification, existing treatment benefits, as well as referral and intervention processes, and analyzing whether benefit and policy changes are needed. The survey can be found here and is available until August 31, 2020.
Status of Generic Albuterol Products Return to Non-preferred August 28, 2020
In response to reported drug shortages for albuterol products in the Bronchodilators, Short-Acting Beta Agonist Inhalers drug class, FirstCare temporarily removed the non-preferred status from the generic formulations on March 20, 2020. FirstCare will reverse this change in status because we determined sufficient availability in the market. For more information including the preferred PDL options, click here.
Managed Care Provider Complaints Flyer and Co-branding
For more information click here.
* Required field
ATTENTION: By clicking “Continue”, you will be leaving the FirstCare Medicare Dual SNP (HMO SNP) site pages. If you wish to remain on these pages, simply click “Cancel” or close this box.